| Financial Year |
March 31 2023 |
| Monetary Funds |
1,817,662,053.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
36,858,180.21 |
| Accounts Receivable |
1,083,724,406.84 |
| Advances to Suppliers |
15,111,253.82 |
| Other Receivables |
60,384,319.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
538,054,023.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
67,312,192.90 |
| Total Current Assets |
3,802,355,440.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,978,594.59 |
| Investment Properties |
-- |
| Fixed Assetes |
2,052,701,453.62 |
| Under-construction Projects |
1,046,113,496.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
96,259,007.99 |
| R&D expenses |
3,599,144.44 |
| Goodwill |
1,071,268,579.93 |
| Long-Term Deferred and Prepaid Expenses |
65,468,428.40 |
| Deferred Income Tax Assets |
123,724,028.19 |
| Other Non-Current Assets |
152,076,704.63 |
| Sub-Total of Non-Current Assets |
4,728,704,289.32 |
| Total Assets |
8,531,059,730.12 |
| Short-Term Loans |
800,261,507.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
257,413,871.08 |
| Accounts Payable |
909,995,786.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,947,870.69 |
| Taxes Payable |
9,388,097.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,792,415.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
282,671,156.11 |
| Other Current Liabilities |
831,418.02 |
| Sub-Total of Current Liabilities |
2,304,693,023.23 |
| Long-term Loans |
827,694,329.57 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
90,247,450.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,052,764,958.32 |
| Total Liabilities |
3,357,457,981.55 |
| Paid-In Capital(Or Share Stock) |
638,023,104.00 |
| Capital Surplus |
3,356,031,100.85 |
| Surplus Reserve |
76,045,190.92 |
| LESS:Treasury Stock |
93,104,733.21 |
| Undistributed Profits |
1,201,447,461.78 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,173,601,748.57 |
| Owner's Equity（Stockholder's Equity） |
5,173,601,748.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,531,059,730.12 |
